PGI13 A COST UTILITY ANALYSIS OF PEGUINTERFERON ALFA 2B (I2KD) (PEG2B)VERSUS PEGUINTERFERON ALFA 2A (40KD) (PEG2A) FOR THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN BRAZIL

May 1, 2006, 00:00
10.1016/S1098-3015(10)64450-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)64450-6/fulltext
Title : PGI13 A COST UTILITY ANALYSIS OF PEGUINTERFERON ALFA 2B (I2KD) (PEG2B)VERSUS PEGUINTERFERON ALFA 2A (40KD) (PEG2A) FOR THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN BRAZIL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64450-6&doi=10.1016/S1098-3015(10)64450-6
First page :
Section Title :
Open access? : No
Section Order : 359
Categories :
Tags :
Regions :
ViH Article Tags :